Navigation Links
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
Date:4/3/2009

PRINCETON, N.J., April 3 /PRNewswire-FirstCall/ -- In conjunction with its first quarter 2009 earnings release (expected to be issued after market close on April 29, 2009), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, April 30, 2009 at 9:00 a.m. ET.

    What:  Covance First Quarter 2009 Earnings Webcast and Slide Presentation
    When:  April 30, 2009, 9:00 a.m. ET*
    Where:http://www.covance.com

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,600 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

*If you are unable to participate during the live webcast, the event will be archived on the web site http://www.covance.com for 14 days.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum
2. Covance to Present at the Barclays Capital Global Healthcare Conference
3. Covance Elects Bradley T. Sheares to Companys Board of Directors
4. Covance to Present at the 2009 UBS Global Healthcare Services Conference
5. Covance Opens Three New Offices in Ukraine, Slovakia, and Israel
6. Covance Reports Fourth Quarter and Full-Year 2008 Results
7. Covance to Present at the 27th Annual J.P. Morgan Healthcare Conference
8. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2008 Financial Results Conference Call
9. Covance Inc. Invites You to Join the Webcast of Its 2009 Guidance Conference Call
10. Covance to Present at the Credit Suisse 2008 Healthcare Conference
11. Covance and Lilly Enter Into a Strategic R&D Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... , ... Elisa Guajardo Carothers is not your typical author. She went from working as a ... she writes about God, when she isn’t swimming as a performing mermaid. , Her book ... (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, before Lucifer ...
(Date:2/27/2017)... , ... February 26, 2017 , ... Miro is the ... sound and video system brings songs, movies, TV shows and much more apps for ... clear, high-definition sound. An immersive view of 1280 x 720 provides crisp images with ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... for RGN-137, GtreeBNT Co., Ltd., received a positive ... 3 clinical trial design for RGN-137 to treat ... healing gel that incorporates Thymosin beta 4 ("Tß4") ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies The global ... CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. ... from 2016 to 2027. The market is estimated at $816m in ... ... to discover how you can exploit the future business opportunities emerging ...
Breaking Medicine Technology: